Related Experiment Video
Updated: Aug 17, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
[DNA diagnosis in hematological malignancies]
1Laboratory Medicine, Tokyo Medical and Dental University.
Abstract:
The recent advances in molecular biology and gene engineering have greatly contributed to the diagnosis and treatment of hematopoietic malignancies, such as leukemia and malignant lymphoma. It is now possible to precisely determine the clonal origin of malignant cells, the subtype of leukemia or lymphoma, and the clinical prognosis in each patient. Furthermore, minimal residual malignant cells in leukemia or lymphoma patients after achieving complete remission can be detected by DNA analysis. Based on these analyses, theoretically treatment can be tailored for each patient. We discuss in the present paper the usefulness of DNA or gene analyses in the clinical laboratory for hematopoietic malignancies.
Related Concept Videos
Karyotyping
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

